A negative feedback signaling network underlies oncogene-induced senescence

被引:424
作者
Courtois-Cox, Stephanie
Williams, Sybil M. Genther
Reczek, Elizabeth E.
Johnson, Bryan W.
McGillicuddy, Lauren T.
Johannessen, Cory M.
Hollstein, Pablo E.
MacCollin, Mia
Cichowski, Karen
机构
[1] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp East, Mol Neurogenet Unit, Boston, MA 02129 USA
关键词
D O I
10.1016/j.ccr.2006.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogene-induced senescence functions to limit tumor development. However, a complete understanding of the signals that trigger this type of senescence is currently lacking. We found that mutations affecting NF1, Raf, and Ras induce a global negative feedback response that potently suppresses Ras and/or its effectors. Moreover, these signals promote senescence by inhibiting the Ras/PI3K pathway, which can impact the senescence machinery through HDM2 and Ill This negative feedback program is regulated in part by RasGEFs, Sprouty proteins, RasGAPs, and MKPs. Moreover, these signals function in vivo in benign human tumors. Thus, the ultimate response to the aberrant activation of the Ras pathway is a multifaceted negative feedback signaling network that terminates the oncogenic signal and participates in the senescence response.
引用
收藏
页码:459 / 472
页数:14
相关论文
共 40 条
  • [31] REPRESSION OF C-FOS TRANSCRIPTION AND AN ALTERED GENETIC PROGRAM IN SENESCENT HUMAN-FIBROBLASTS
    SESHADRI, T
    CAMPISI, J
    [J]. SCIENCE, 1990, 247 (4939) : 205 - 209
  • [32] Developmental regulation and overexpression of the transcription factor AP-2, a potential regulator of the timing of Schwann cell generation
    Stewart, HJS
    Brennan, A
    Rahman, M
    Zoidl, G
    Mitchell, PJ
    Jessen, KR
    Mirsky, R
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 14 (02) : 363 - 372
  • [33] An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis
    Sweet-Cordero, A
    Mukherjee, S
    Subramanian, A
    You, H
    Roix, JJ
    Ladd-Acosta, C
    Mesirov, J
    Golub, TR
    Jacks, T
    [J]. NATURE GENETICS, 2005, 37 (01) : 48 - 55
  • [34] Tresini M, 1998, CANCER RES, V58, P1
  • [35] Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma
    Tsao, H
    Goel, V
    Wu, H
    Yang, G
    Haluska, FG
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (02) : 337 - 341
  • [36] Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects
    Tuveson, DA
    Shaw, AT
    Willis, NA
    Silver, DP
    Jackson, EL
    Chang, S
    Mercer, KL
    Grochow, R
    Hock, H
    Crowley, D
    Hingorani, SR
    Zaks, T
    King, C
    Jacobetz, MA
    Wang, LF
    Bronson, RT
    Orkin, SH
    DePinho, RA
    Jacks, T
    [J]. CANCER CELL, 2004, 5 (04) : 375 - 387
  • [37] Wei S, 1999, CANCER RES, V59, P1539
  • [38] Role of p14ARF in replicative and induced senescence of human fibroblasts
    Wei, WY
    Hemmer, RM
    Sedivy, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) : 6748 - 6757
  • [39] Senescence of human fibroblasts induced by oncogenic Raf
    Zhu, JY
    Woods, D
    McMahon, M
    Bishop, JM
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2997 - 3007
  • [40] Neurofibromas in NF1: Schwann cell origin and role of tumor environment
    Zhu, Y
    Ghosh, P
    Charnay, P
    Burns, DK
    Parada, LF
    [J]. SCIENCE, 2002, 296 (5569) : 920 - 922